These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24387993)

  • 1. Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease.
    Basmanav FB; Oprisoreanu AM; Pasternack SM; Thiele H; Fritz G; Wenzel J; Größer L; Wehner M; Wolf S; Fagerberg C; Bygum A; Altmüller J; Rütten A; Parmentier L; El Shabrawi-Caelen L; Hafner C; Nürnberg P; Kruse R; Schoch S; Hanneken S; Betz RC
    Am J Hum Genet; 2014 Jan; 94(1):135-43. PubMed ID: 24387993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease.
    Li M; Cheng R; Liang J; Yan H; Zhang H; Yang L; Li C; Jiao Q; Lu Z; He J; Ji J; Shen Z; Li C; Hao F; Yu H; Yao Z
    Am J Hum Genet; 2013 Jun; 92(6):895-903. PubMed ID: 23684010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of POFUT1 gene mutation in a Chinese family with Dowling-Degos disease.
    Chen M; Li Y; Liu H; Fu X; Yu Y; Yu G; Wang C; Bao F; Liany H; Wang Z; Shi Z; Zhang D; Zhou G; Liu J; Zhang F
    PLoS One; 2014; 9(8):e104496. PubMed ID: 25157627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa.
    Ralser DJ; Basmanav FB; Tafazzoli A; Wititsuwannakul J; Delker S; Danda S; Thiele H; Wolf S; Busch M; Pulimood SA; Altmüller J; Nürnberg P; Lacombe D; Hillen U; Wenzel J; Frank J; Odermatt B; Betz RC
    J Clin Invest; 2017 Apr; 127(4):1485-1490. PubMed ID: 28287404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in POGLUT1 in Galli-Galli/Dowling-Degos disease.
    Wilson NJ; Cole C; Kroboth K; Hunter WN; Mann JA; McLean WH; Kernland Lang K; Beltraminelli H; Sabroe RA; Tiffin N; Sobey GJ; Borradori L; Simpson E; Smith FJ
    Br J Dermatol; 2017 Jan; 176(1):270-274. PubMed ID: 27479915
    [No Abstract]   [Full Text] [Related]  

  • 6. Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease.
    Kono M; Sugiura K; Suganuma M; Hayashi M; Takama H; Suzuki T; Matsunaga K; Tomita Y; Akiyama M
    Hum Mol Genet; 2013 Sep; 22(17):3524-33. PubMed ID: 23666529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Notch Signaling in Dowling-Degos Disease: Additional Mutations in POGLUT1 and Further Insights into Disease Pathogenesis.
    Ralser DJ; Takeuchi H; Fritz G; Basmanav FB; Effern M; Sivalingam S; El-Shabrawi-Caelen L; Degirmentepe EN; Kocatürk E; Singh M; Booken N; Spierings NMK; Schnabel V; Heineke A; Knuever J; Wolf S; Wehner M; Tronnier M; Leverkus M; Tantcheva-Poór I; Wenzel J; Oji V; Has C; Hölzel M; Frank J; Haltiwanger RS; Betz RC
    J Invest Dermatol; 2019 Apr; 139(4):960-964. PubMed ID: 30414910
    [No Abstract]   [Full Text] [Related]  

  • 8. Dowling-Degos disease: a review.
    Stephan C; Kurban M; Abbas O
    Int J Dermatol; 2021 Aug; 60(8):944-950. PubMed ID: 33368260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Japanese Case of Galli-Galli Disease due to a Previously Unreported POGLUT1 Mutation.
    Kono M; Sawada M; Nakazawa Y; Ogi T; Muro Y; Akiyama M
    Acta Derm Venereol; 2019 Apr; 99(4):458-459. PubMed ID: 30653241
    [No Abstract]   [Full Text] [Related]  

  • 10. Dowling-Degos disease with mutations in POFUT1 is clinicopathologically distinct from reticulate acropigmentation of Kitamura.
    Kono M; Suganuma M; Takama H; Zarzoso I; Saritha M; Bodet D; Aboobacker S; Kaliaperumal K; Suzuki T; Tomita Y; Sugiura K; Akiyama M
    Br J Dermatol; 2015 Aug; 173(2):584-6. PubMed ID: 25639155
    [No Abstract]   [Full Text] [Related]  

  • 11. A new nonsense mutation in the POGLUT1 gene in two sisters with Dowling-Degos disease.
    Duchatelet S; Clerc H; Machet L; Gaboriaud P; Miskinyte S; Kervarrec T; Hovnanian A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):e440-e442. PubMed ID: 29569780
    [No Abstract]   [Full Text] [Related]  

  • 12. Founder Variants in KRT5 and POGLUT1 Are Implicated in Dowling-Degos Disease.
    Kumar S; Borisov O; Maj C; Ralser DJ; Humbatova A; Hanneken S; Schmieder A; Groß J; Maintz L; Heineke A; Knuever J; Fagerberg C; Parmentier L; Anemüller W; Oji V; Tantcheva-Poór I; Fölster-Holst R; Wenzel J; Krawitz PM; Frank J; Betz RC
    J Invest Dermatol; 2024 Jan; 144(1):181-184. PubMed ID: 37468035
    [No Abstract]   [Full Text] [Related]  

  • 13. Dowling-Degos disease co-presenting with Darier disease.
    Strausburg M; Linos K; Staser K; Mousdicas N
    Clin Exp Dermatol; 2016 Jun; 41(4):410-2. PubMed ID: 26685052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated papular variant of Dowling-Degos disease: Histopathological features in POGLUT1 mutation.
    Papadopoulou K; Karsai S; Böer-Auer A
    J Dtsch Dermatol Ges; 2022 Nov; 20(11):1423-1429. PubMed ID: 36314591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRT5 mutation regulate melanin metabolism through notch signalling pathway between keratinocytes and melanocytes.
    Jia W; Zhang Y; Wang X; Luo L; Sun H; Jiang Y; Wang J; Mao Q; Guo Y; Kong L; Mo R; Li C
    Exp Dermatol; 2023 Jun; 32(6):752-765. PubMed ID: 36809573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical presentation of Dowling-Degos disease with novel and recurrent mutations in POFUT1.
    Zhong W; Liu J; Wang H; Dou X; Yu B; Lin Z; Yang Y
    Clin Exp Dermatol; 2018 Dec; 43(8):937-939. PubMed ID: 29797344
    [No Abstract]   [Full Text] [Related]  

  • 17. Genome-wide linkage and exome sequencing analyses identify an initiation codon mutation of KRT5 in a unique Chinese family with generalized Dowling-Degos disease.
    Li M; Wang J; Zhang J; Ni C; Li X; Liang J; Cheng R; Li Z; Yao Z
    Br J Dermatol; 2016 Mar; 174(3):663-6. PubMed ID: 26440693
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenicity of POFUT1 in Dowling-Degos disease: additional mutations and clinical overlap with reticulate acropigmentation of kitamura.
    Buket Basmanav F; Fritz G; Lestringant GG; Pachat D; Hoffjan S; Fischer J; Wehner M; Wolf S; Thiele H; Altmüller J; Pulimood SA; Rütten A; Kruse R; Hanneken S; Frank J; Danda S; Bygum A; Betz RC
    J Invest Dermatol; 2015 Feb; 135(2):615-618. PubMed ID: 25229252
    [No Abstract]   [Full Text] [Related]  

  • 19. A phenotype combining hidradenitis suppurativa with Dowling-Degos disease caused by a founder mutation in PSENEN.
    Pavlovsky M; Sarig O; Eskin-Schwartz M; Malchin N; Bochner R; Mohamad J; Gat A; Peled A; Hafner A; Sprecher E
    Br J Dermatol; 2018 Feb; 178(2):502-508. PubMed ID: 28922471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of human POFUT1, its requirement in ligand-independent oncogenic Notch signaling, and functional effects of Dowling-Degos mutations.
    McMillan BJ; Zimmerman B; Egan ED; Lofgren M; Xu X; Hesser A; Blacklow SC
    Glycobiology; 2017 Aug; 27(8):777-786. PubMed ID: 28334865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.